Related Experiment Videos
Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling
Suk Woo Nam1, Jik Young Park, Adaikalavan Ramasamy
1Department of Pathology, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul, South Korea.
Hepatology (Baltimore, Md.)
|September 22, 2005
Summary
Molecular analysis reveals distinct gene expression patterns that differentiate hepatocellular carcinoma (HCC) grades and pre-neoplastic lesions. This molecular demarcation aids in understanding liver cancer progression.
Area of Science:
- Hepatocellular Carcinoma Research
- Molecular Oncology
- Genomics
Background:
- Hepatocellular carcinoma (HCC) progression involves pre-neoplastic lesions like low-grade dysplastic nodules (LGDNs) and high-grade dysplastic nodules (HGDNs).
- Molecular changes driving HCC progression and distinguishing pre-neoplastic from cancerous lesions remain unclear.
- Morphological criteria for differentiating these stages are not universally agreed upon.
Purpose of the Study:
- To investigate the molecular underpinnings of hepatocellular carcinoma (HCC) progression using gene expression profiling.
- To identify molecular differences between pre-neoplastic lesions (LGDNs, HGDNs) and varying grades of HCC.
- To establish a molecular basis for classifying HCC stages.
Main Methods:
- Oligonucleotide microarrays were used to analyze transcription profiles of 50 hepatocellular nodular lesions.
- Unsupervised hierarchical clustering of 10,376 genes was employed to differentiate lesion types and HCC grades.
- Statistical analyses (ANOVA, t-tests) and machine learning (LDA, SVM) were used to identify grade-associated genes and classifiers.
Main Results:
- Gene expression profiles successfully discriminated between dysplastic nodules and HCC, as well as between different HCC histological grades.
- 3,084 genes correlated with tumor progression were identified.
- A panel of 240 genes accurately classified tumors by histological grade, particularly distinguishing LGDNs, HGDNs, and grade 1 HCC.
Conclusions:
- A distinct molecular boundary exists between dysplastic nodules and overt hepatocellular carcinoma (HCC).
- HCC progression from grade 1 to grade 3 is associated with significant gene expression changes.
- These molecular alterations reflect functional changes consistent with cancer development and progression.